Cargando…

Risk selection into supplemental private health insurance in China

BACKGROUND: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yawen, Ni, Weiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918563/
https://www.ncbi.nlm.nih.gov/pubmed/31848759
http://dx.doi.org/10.1186/s13561-019-0252-8
_version_ 1783480614345768960
author Jiang, Yawen
Ni, Weiyi
author_facet Jiang, Yawen
Ni, Weiyi
author_sort Jiang, Yawen
collection PubMed
description BACKGROUND: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively mature. However, evidence on this important aspect of the supplemental PHI market in China is still absent in the literature. The private insurers in China were not prohibited from discrimination against pre-existing conditions and did not guarantee ongoing enrolment. Therefore, the direction and degree of risk selection could not be inferred using the evidence from the other countries. To provide evidence on risk selection into supplemental PHI in China, we conducted a cross-sectional analysis using data from the 2015 wave of China Health and Retirement Longitudinal Study (CHARLS). RESULTS: Using probit models, we found that individuals having better self-reported general health were more likely to enrol in PHI in China, suggesting advantageous selection. This result was confirmed by an alternative analysis using an instrumental variable. We also adjusted the realized occurrence of hospitalization by excluding potential moral hazard effect and showed that the adjusted hospitalization risk was negatively associated with PHI enrolment, which also indicated advantageous selection. CONCLUSIONS: The findings suggested potential over-insurance of healthier individuals or under-insurance of less healthy individuals. The regulation of the PHI market in China should aim to address the inefficiency. The current study could also contribute to the information base for policymakers in countries where the PHI markets similarly lack strong regulation.
format Online
Article
Text
id pubmed-6918563
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69185632019-12-30 Risk selection into supplemental private health insurance in China Jiang, Yawen Ni, Weiyi Health Econ Rev Research BACKGROUND: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively mature. However, evidence on this important aspect of the supplemental PHI market in China is still absent in the literature. The private insurers in China were not prohibited from discrimination against pre-existing conditions and did not guarantee ongoing enrolment. Therefore, the direction and degree of risk selection could not be inferred using the evidence from the other countries. To provide evidence on risk selection into supplemental PHI in China, we conducted a cross-sectional analysis using data from the 2015 wave of China Health and Retirement Longitudinal Study (CHARLS). RESULTS: Using probit models, we found that individuals having better self-reported general health were more likely to enrol in PHI in China, suggesting advantageous selection. This result was confirmed by an alternative analysis using an instrumental variable. We also adjusted the realized occurrence of hospitalization by excluding potential moral hazard effect and showed that the adjusted hospitalization risk was negatively associated with PHI enrolment, which also indicated advantageous selection. CONCLUSIONS: The findings suggested potential over-insurance of healthier individuals or under-insurance of less healthy individuals. The regulation of the PHI market in China should aim to address the inefficiency. The current study could also contribute to the information base for policymakers in countries where the PHI markets similarly lack strong regulation. Springer Berlin Heidelberg 2019-12-17 /pmc/articles/PMC6918563/ /pubmed/31848759 http://dx.doi.org/10.1186/s13561-019-0252-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Jiang, Yawen
Ni, Weiyi
Risk selection into supplemental private health insurance in China
title Risk selection into supplemental private health insurance in China
title_full Risk selection into supplemental private health insurance in China
title_fullStr Risk selection into supplemental private health insurance in China
title_full_unstemmed Risk selection into supplemental private health insurance in China
title_short Risk selection into supplemental private health insurance in China
title_sort risk selection into supplemental private health insurance in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918563/
https://www.ncbi.nlm.nih.gov/pubmed/31848759
http://dx.doi.org/10.1186/s13561-019-0252-8
work_keys_str_mv AT jiangyawen riskselectionintosupplementalprivatehealthinsuranceinchina
AT niweiyi riskselectionintosupplementalprivatehealthinsuranceinchina